What opportunities in 2025 might we regret—years later—just as we now regret missing Bitcoin?

Yes. Right now. AVNT: rose from $0.3 to $1.5 in just three days. I didn’t hold on. I sold at $0.45. Last month’s MYX: up 300x. OKB in July. There’s one every month. It’s just a matter of whether you’re willing to believe. Another promising one is coming in a few days.

Top Five Healthcare M&A Events of 2024

12. Siemens Healthineers acquired Novartis’ Advanced Accelerator Applications (AAA), expanding its molecular imaging capabilities. This transaction added 13 European manufacturing sites to Siemens’ PETNET Solutions network, strengthening its capacity for producing and delivering OEM PET radiopharmaceuticals. Approximately 420 newly integrated employees will operate under Siemens Healthineers as Advanced Accelerator Applications. According to Siemens, the covered PET diagnostics market—driven by innovations in tracers for oncology, neurology, and cardiology—is valued at €500 million annually and is projected to triple by 2033. PETNET Solutions is the global leader in PET radiopharmaceutical production and distribution, supplying nearly 1.6 million doses annually to over 2,800 imaging centers worldwide. 4. Duke Street acquired AGITO Medical from Philips In July, European private equity firm Duke Street acquired Denmark-based AGITO Medical—a mobile imaging equipment leasing and pre-owned imaging systems supplier—from Philips. Founded in 2004, AGITO provides flexible, tailored mobile imaging leasing solutions and supplies pre-owned imaging equipment and spare parts to healthcare providers. It offers hospitals and clinics mobile imaging services—including CT, MR, and ECG suites—with or without staffing support. James Almond, Managing Partner at Duke Street, described the investment as a ‘classic’ private equity deal: spinning out an excellent healthcare product and team from a global corporate entity, then creating value for all stakeholders through a dedicated investment plan. The European medical imaging leasing market is currently valued at approximately €500 million and is expected to grow 6–7% annually over the next several years. 5. Avante Health Solutions filed for bankruptcy and agreed to be sold In October, Avante Health Solutions and its affiliated entities filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the District of Delaware on October 8, to facilitate their sale to private equity firm Staple Street Capital. The company listed assets between $50 million and $100 million, and liabilities between $100 million and $500 million—including its 30 largest unsecured creditors, led by Philips Medical Systems. Jim Leitl, CEO and President of Avante, stated: “Facing an increasingly difficult situation due to ongoing litigation, our team has been striving to strengthen our financial foundation. Over the past several years, Avante has incurred losses totaling approximately $20 million.”

Avient Corporation (AVNT) Stock Forecasts

Oct 15, 2026

Argus Research lowered its price target for Avient Corporation, a chemical and plastic manufacturer, to $42.00 while the stock currently trades at $38.85.

Yahoo! Finance Canada

2026-02-13

Avient narrowly beats estimates, expects growth in 2026

2026-04-02

Avient Director Adds 1,072 Shares via Deferred Comp Plan

2026-04-02

Avient Director Adds 1,072 Shares via Deferred Comp Award

2026-04-18

Avient (AVNT) Q4 Earnings and Revenues Beat Estimates

2026-06-08

Avient Reports First-Quarter Earnings Above Expectations